Limitations of Semi-Automated Immunomagnetic Separation of HLA-G-Positive Trophoblasts from Papanicolaou Smears for Prenatal Genetic Diagnostics
<b>Background:</b> In prenatal genetic diagnostics, the detection of single-gene defects relies on chorionic villus sampling (CVS) and amniocentesis, which carry a miscarriage risk of 0.2-0.3%. To mitigate this risk, fetal trophoblasts have been isolated from a Papanicolaou smear using Trophoblast Retrieval and Isolation from the Cervix (TRIC). However, this method is labor-intensive and has been shown to be challenging to implement in clinical practice. Here, we describe our experiences in using semi-automated immunomagnetic cell sorting for isolating trophoblasts from clinically obtained Papanicolaou smears during ongoing pregnancies. <b>Methods:</b> Using HLA-G-positive Jeg-3 and HLA-G-negative HeLa cell lines in 10%, 1%, and 0.1% dilutions, we tested and optimized the isolation of HLA-G-positive cells using FACS and semi-automated immunomagnetic cell sorting. We used the latter technique for isolation of HLA-G-positive cells from Papanicolaou smears collected from 26 pregnant women, gestational age between 6 and 20 weeks, who underwent CVS. <b>Results:</b> In four independent dilution series, the mean percentages of Jeg-3 cells went from 7.1% to 53.5%, 0.9% to 32.6%, and 0.4% to 2.6% (7.5, 36, and 6.5-fold enrichment, respectively) using immunomagnetic cell sorting. After sorting of the Papanicolaou smears, HLA-G-positive cells were moderately increased in the positive (14.61 vs. 11.63%) and decreased in the negative fraction (7.87 vs. 11.63%) compared to baseline pre-sorting. However, we could not identify fetal cells using XY-chromosomal FISH in a male sample. <b>Conclusions:</b> Our study supports previous findings that careful sampling of fetal cells from Papanicolaou smears in a clinical context poses significant challenges to cell retrieval.
Authors
- Gerard J. te Meerman (ORCID: https://orcid.org/0000-0002-5615-8304)
- Eddy N. de Boer (ORCID: https://orcid.org/0000-0002-7138-8642)
- Nicole Corsten‐Janssen (ORCID: https://orcid.org/0000-0002-9438-2374)
- Elles Wierenga
- Theo Bijma (ORCID: https://orcid.org/0000-0002-1522-9137)
- L. Duin (ORCID: https://orcid.org/0000-0003-4089-9973)
- Cleo C. van Diemen (ORCID: https://orcid.org/0000-0001-9283-2207)
- N. Knoers (ORCID: https://orcid.org/0009-0001-2916-1524)
- G. T. R. Manten
- Jurjen T. Knapper
- Katelijne Bouman (ORCID: https://orcid.org/0000-0001-9253-8200)
Institutions
- University Medical Center Groningen (NL)
- University of Groningen (NL)
- Isala (NL)
Publication Details
- Journal
- Diagnostics
- Published
- 2025-02-06
- DOI
- https://doi.org/10.3390/diagnostics15030386
- Citations
- 1
- Primary Topic
- Prenatal Screening and Diagnostics
- Type
- article
- Field-Weighted Citation Impact
- 3.49
Funders
- Universitair Medisch Centrum Groningen
- Gratama Stichting